Prospective evaluation of echocardiography and serum biomarkers as predictors of cardiotoxicity in patients with breast cancer treated with anthracyclines, taxanes, with/without trastuzumab.

J. Soler Lopez, Angel Solloso, María De Julián et al.|Journal of Clinical Oncology|2014

Cited by 3